Development, Validation, and Clinical Application of LC-MS/MS Method for Simultaneous Determination of Ibrutinib, Zanubrutinib, Orelabrutinib, Acalabrutinib, and Their Active Metabolites in Patients with B-cell Lymphoma
Analytical and Bioanalytical Chemistry（2024）
Key words
BTK inhibitors,Therapeutic drug monitoring,LC-MS/MS,B-cell lymphoma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined